←back to thread

Cost of developing new drugs may be lower than industry claims: trial

(www.theguardian.com)
275 points swores | 1 comments | 25 Apr 24 12:25 UTC | HN request time: 0.209s | source
Show context
hi-v-rocknroll ◴[26 Apr 24 19:23 UTC] No.40173019[source]▶
Semaglutide retails for $17k USD/year in the US but costs only $60 to make. Perhaps it could be argued that the autoinjectors are "expensive", but not $17k/year and oral forms are coming online to make this item moot. In limited circumstances, excessive profits cross into the realm of price gouging and shouldn't be allowed by regulatory enforcement.
replies(9): >>40173117 #>>40173204 #>>40173218 #>>40173309 #>>40173371 #>>40173374 #>>40173583 #>>40173707 #>>40174265 #
1. SkyPuncher ◴[26 Apr 24 20:04 UTC] No.40173583[source]▶
“But it only costs X” is not a great argument. Most of tech jobs would be gone if things had to be within a fraction of what they cost to deliver.

The world runs on value. Coat is simply a limiting factor in the floor that something can be made for.